找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cervical Cancer; Jaime G. de la Garza-Salazar,Flavia Morales-Vásque Book 2017 Springer International Publishing Switzerland 2017 cervical

[復(fù)制鏈接]
樓主: PLY
41#
發(fā)表于 2025-3-28 18:03:43 | 只看該作者
42#
發(fā)表于 2025-3-28 20:33:18 | 只看該作者
43#
發(fā)表于 2025-3-29 00:38:28 | 只看該作者
Cervical Cancer Cytology and Pathology,al/vaginal cytology, including recommendations for a proper cytologic report. Furthermore, the main cytologic criteria used in the diagnosis of squamous and glandular invasive cervical neoplasia precursor lesions are included. In the final part of the cytology section, some advantages and drawbacks
44#
發(fā)表于 2025-3-29 05:27:32 | 只看該作者
45#
發(fā)表于 2025-3-29 10:22:37 | 只看該作者
Imaging in Cervical Cancer,tion of Gynecology and Obstetrics (FIGO) criteria, cancer staging systems have been shown to be deficient for the examination of prognostic factors of CC, including tumor size and infiltration of the parametria or pelvic wall, as well as for the evaluation of nodal metastases. In this regard, imagin
46#
發(fā)表于 2025-3-29 11:55:42 | 只看該作者
47#
發(fā)表于 2025-3-29 18:10:22 | 只看該作者
Surgical Treatment for Advanced or Recurrent Disease in Cervical Cancer,nding on the survival disease-free, the site and size of recurrence can be set 5-year survivals of 48–60%. Since it was first reported in 1948, pelvic exenteration has been used in the treatment of advanced pelvic cancers. The original procedure has been modified in an attempt to preserve urinary or
48#
發(fā)表于 2025-3-29 21:19:26 | 只看該作者
49#
發(fā)表于 2025-3-30 00:32:03 | 只看該作者
50#
發(fā)表于 2025-3-30 04:02:04 | 只看該作者
Immuno-Oncology in Cervical Cancer,une-mediated treatments, or immuno-oncology, currently represent 6% of cancer therapies, and in the next 10 years, this percentage is expected to increase up to 70%. There are ongoing efforts to develop specific immunotherapies, such as immunomodulatory drugs and antibodies, to treat CC in combinati
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 18:52
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
青神县| 论坛| 洛隆县| 措勤县| 泰来县| 黔西县| 双流县| 富阳市| 镇平县| 新兴县| 射阳县| 张家港市| 安岳县| 蓬安县| 南雄市| 东乡县| 汪清县| 临汾市| 永年县| 台南市| 富宁县| 乐业县| 开化县| 乌审旗| 荃湾区| 洪湖市| 扎兰屯市| 平山县| 米易县| 宁河县| 永顺县| 西宁市| 南陵县| 靖安县| 巩义市| 马关县| 什邡市| 紫阳县| 枞阳县| 左云县| 宜兴市|